Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
Sentra, a database of signal transduction proteins.
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. Am J Cardiol. 2008 Mar 01; 101(5):625-30.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Creatine Kinase
Cross-Over Studies
Delayed-Action Preparations
Dose-Response Relationship, Drug
Drug Therapy, Combination
Dyslipidemias
Female
Flushing
Humans
Hypolipidemic Agents
Indoles
Male
Middle Aged
Niacin
Receptors, Immunologic
Receptors, Prostaglandin
authors with profiles
Michael Davidson